Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drugFirst approved 2017

Ozempic(Semaglutide)Novo Nordisk A/S logoNVO

Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by Novo Nordisk A/S

$12.97B

Medicare cost, 2024

Medicare drug plans spent $13.0 billion on Ozempic (semaglutide) in 2024, for 10.4 million prescriptions and refills filled by 2.0 million patients. It ranks 2nd among all drugs by Medicare drug plan spending. Spending rose 41% from 2023 to 2024. Texas accounts for the most spending ($1.2 billion, 9% of the total).

Medicare cost, 2024

$12.97B

+41.1% from 2023

Prescriptions

10.4M

$1,245.09 per claim

Patients

2.0M

286,517 prescribers

Total spending, 2024

$12.97B

$6,642.45 per patient

Questions and answers

How much does Medicare spend on Ozempic?

Medicare prescription drug plans paid $12.97B for Ozempic in 2024, for 10,413,554 prescriptions and refills to 1,951,892 patients (up 41.1% from 2023). The average cost per claim was $1,245.09.

Which state spends the most on Ozempic?

Texas had the highest Medicare cost for Ozempic in 2024: $1.18B for 912,298 claims, followed by California ($1.10B).

Who prescribes Ozempic the most?

Eugenio Angueira-Serrano, endocrinology in Miami, FL, had the highest Medicare cost for Ozempic in 2024: 5,444 claims costing $5.8M.

Who makes Ozempic?

Ozempic is made by Novo Nordisk A/S (NVO), listed in the Medicare spending data as Novo Nordisk.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Ozempic was $12.97B in 2024, the highest year shown.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Ozempic, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Eugenio Angueira-Serrano Miami, FLEndocrinology5,444885$5.8M
Stella Ilyayeva Rego Park, NYInternal Medicine3,061582$3.2M
Monica G Robles Anniston, ALEndocrinology1,675379$2.5M
Syed A Hassan Harlingen, TXEndocrinology1,506380$2.4M
Bashar G Saad San Dimas, CAEndocrinology2,138447$2.4M
Lane M Frey Thibodaux, LAEndocrinology1,296306$2.3M
Ronald B Villanueva Lakewood, NJEndocrinology1,154292$2.3M
Stephan Kowalyk Greensburg, PAEndocrinology1,983348$2.3M
Kandaswamy Jayaraj Beaumont, TXEndocrinology1,321301$2.1M
Brian E Burtch Willoughby, OHEndocrinology1,281308$2.0M
Cheng-Yang C Tuan San Francisco, CAEndocrinology1,180260$2.0M
Vinay Kapoor Bayside, NYEndocrinology994243$1.9M
Irina A Urusova Los Angeles, CAEndocrinology1,999256$1.9M
Alisha Mason Ripley, MSFamily Practice724280$1.9M
Phong H Bui Fountain Valley, CAInternal Medicine1,314230$1.9M
Ralph Oiknine Chesterfield, MOEndocrinology1,073243$1.9M
Juan D Palacios Merchan Edinburg, TXEndocrinology1,382268$1.8M
Farhad Farjoudi San Diego, CAEndocrinology1,165273$1.8M
Ahmed F Al Jebawi Anderson, INEndocrinology1,152252$1.8M
Kalyani Regeti North Port, FLEndocrinology903233$1.8M
Sharon H Kim Bronx, NYEndocrinology1,256233$1.7M
Ahmet B Ergin Port St Lucie, FLEndocrinology1,108278$1.7M
Anju Gurung Fayetteville, NCInternal Medicine1,017222$1.7M
Benito A Marranzini El Paso, TXEndocrinology905236$1.7M
Nidhi Jain Little Rock, AREndocrinology1,539280$1.7M

Prescriber data by year

YearPrescribersClaimsPatientsCost
2022179,8313,410,067780,031$4.63B
2023254,4766,925,6671,463,887$9.19B
2024286,51710,413,5541,951,892$12.97B

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Novo NordiskNVO logoNVO10,417,182$12.97B

Medicaid spending by quarter

Amount reimbursed by state Medicaid programs, all states

Amount reimbursed

Codes

National drug codes (packages)
8
RxNorm concept IDs
2398841, 2398842, 2599362, 2599365, 2619152
Application numbers
NDA209637

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube